home / stock / clxt / clxt news


CLXT News and Press, Calyxt Inc. From 09/07/22

Stock Information

Company Name: Calyxt Inc.
Stock Symbol: CLXT
Market: NASDAQ
Website: calyxt.com

Menu

CLXT CLXT Quote CLXT Short CLXT News CLXT Articles CLXT Message Board
Get CLXT Alerts

News, Short Squeeze, Breakout and More Instantly...

CLXT - Calyxt to Present at the H.C. Wainwright 24th Annual Global Investment Conference

Calyxt to Present at the H.C. Wainwright 24th Annual Global Investment Conference PR Newswire ROSEVILLE, Minn. , Sept. 7, 2022 /PRNewswire/ -- Calyxt, Inc. (Nasdaq: CLXT), a plant-based synthetic biology company, today announced that Michae...

CLXT - Calyxt, Inc. (CLXT) CEO Michael Carr on Q2 2022 Results - Earnings Call Transcript

Calyxt, Inc. (CLXT) Q2 2022 Earnings Conference Call August 4, 2022 16:30 ET Company Participants Bill Koschak - Chief Financial Officer Michael Carr - President and Chief Executive Officer Conference Call Participants Bobby Burleson - Canaccord Amit ...

CLXT - Calyxt, Inc. 2022 Q2 - Results - Earnings Call Presentation

The following slide deck was published by Calyxt, Inc. in conjunction with their 2022 Q2 earnings call. For further details see: Calyxt, Inc. 2022 Q2 - Results - Earnings Call Presentation

CLXT - Calyxt Q2 Non-GAAP EPS of -$0.36, revenue of $1.35M

Calyxt press release ( NASDAQ: CLXT ): Q2 Non-GAAP EPS of -$0.36 (vs. -$0.80 Y/Y). Revenue of $1.35M (-87.9% Y/Y). For further details see: Calyxt Q2 Non-GAAP EPS of -$0.36, revenue of $1.35M

CLXT - Calyxt Reports Second Quarter 2022 Financial Results and Provides Corporate Update

Calyxt Reports Second Quarter 2022 Financial Results and Provides Corporate Update PR Newswire Evaluated nine new customer demand-driven plant-based chemistries in the quarter, bringing cumulative chemistries evaluated for development to 95, of these 31 meet Calyxt's t...

CLXT - Calyxt to Present at the Canaccord Genuity 42nd Annual Growth Conference

Calyxt to Present at the Canaccord Genuity 42nd Annual Growth Conference PR Newswire ROSEVILLE, Minn. , July 28, 2022 /PRNewswire/ -- Calyxt, Inc. (Nasdaq: CLXT), a plant-based synthetic biology company, today announced that Michael A. Carr , ...

CLXT - Calyxt to Host Second Quarter 2022 Financial Results Conference Call and Webcast on Thursday, August 4, 2022, at 4:30 p.m. Eastern Time

Calyxt to Host Second Quarter 2022 Financial Results Conference Call and Webcast on Thursday, August 4, 2022, at 4:30 p.m. Eastern Time PR Newswire ROSEVILLE, Minn. , July 21, 2022 /PRNewswire/ -- Calyxt, Inc. (Nasdaq: CLXT), a plant-based synthet...

CLXT - Calyxt to Present at Upcoming Conferences

Calyxt to Present at Upcoming Conferences PR Newswire ROSEVILLE, Minn. , May 17, 2022 /PRNewswire/ -- Calyxt , Inc. (Nasdaq: CLXT), a plant-based synthetic biology company, today announced that management will participate in the following upco...

CLXT - Calyxt, Inc. (CLXT) CEO Michael Carr on Q1 2022 Results - Earnings Call Transcript

Calyxt, Inc. (CLXT) Q1 2022 Earnings Conference Call May 5, 2022 16:30 ET Company Participants Bill Koschak - Chief Financial Officer Michael Carr - President and Chief Executive Officer Conference Call Participants Bobby Burleson - Canaccord Amit Dayal - H.C. Wainwright Brian Wright - ROTH C...

CLXT - Calyxt Non-GAAP EPS of -$0.14 beats by $0.03, revenue of $0.03M misses by $0.35M

Calyxt press release (NASDAQ:CLXT): Q1 Non-GAAP EPS of -$0.14 beats by $0.03. Revenue of $0.03M (-99.3% Y/Y) misses by $0.35M. Shares +4%. For further details see: Calyxt Non-GAAP EPS of -$0.14 beats by $0.03, revenue of $0.03M misses by $0.35M

Previous 10 Next 10